Role of c-myc protein in hormone refractory prostate carcinoma: Cellular response to paclitaxel

Giuliana Cassinelli, Rosanna Supino, Valentina Zuco, Cinzia Lanzi, A. Ivana Scovassi, Sean C. Semple, Franco Zunino

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Amplification of the c-MYC proto-oncogene is a frequent alteration in hormone refractory prostate carcinomas (HRPC). In an attempt to investigate the role of c-myc in the cellular response to paclitaxel (PTX), we used two HRPC cell lines, DU145 and PC3, characterised by different levels of the protein and by different behaviour in response to taxane. In both cell lines, PTX-induced cell death was a caspase-mediated apoptosis. In DU145 cells, PTX induced an early apoptotic response associated with upregulation of c-myc restricted to the G2/M cell population. This event appeared delayed in the presence of c-myc antisense (AS-c-myc), suggesting an upstream regulation of the protein expression. In addition, the antisense approach provided evidence of an involvement of c-myc in the apoptotic response to the taxane. In contrast, in PC3 cells, the overexpressed c-myc was not modulated by drug-treatment and the addition of AS-c-myc did not affect the cell growth inhibition of PTX. In both cell lines, PTX-induced c-myc phosphorylation was concomitant with the mitotic arrest and not related to the modulation of the activation state of AKT and MAPK kinases. Our data indicate that the cellular response to PTX of HRPC cells can involve c-myc and suggest that its pro-apoptotic role is affected by the genetic background, thus supporting a complex and differentiated HRPC cell response to taxanes.

Original languageEnglish
Pages (from-to)923-931
Number of pages9
JournalBiochemical Pharmacology
Volume68
Issue number5
DOIs
Publication statusPublished - Sep 1 2004

Fingerprint

Proto-Oncogene Proteins c-myc
Paclitaxel
Refractory materials
Prostate
Hormones
Carcinoma
Cells
Cell Line
Drug therapy
Taxoids
Phosphorylation
Proto-Oncogenes
Mitogen-Activated Protein Kinase Kinases
Cell growth
Cell death
Caspases
Amplification
Proteins
Cell Death
Up-Regulation

Keywords

  • AS-c-myc
  • c-myc
  • c-myc antisense
  • hormone refractory prostate carcinoma
  • HRPC
  • ODN
  • oligodeoxynucleotide
  • paclitaxel
  • Paclitaxel
  • PI
  • propidium iodide
  • Prostatic neoplasms
  • PTX
  • Scr-ODN
  • scrambled oligodeoxynucleotide
  • TdT-mediated dUTP nick-end labelling
  • TUNEL

ASJC Scopus subject areas

  • Pharmacology

Cite this

Role of c-myc protein in hormone refractory prostate carcinoma : Cellular response to paclitaxel. / Cassinelli, Giuliana; Supino, Rosanna; Zuco, Valentina; Lanzi, Cinzia; Scovassi, A. Ivana; Semple, Sean C.; Zunino, Franco.

In: Biochemical Pharmacology, Vol. 68, No. 5, 01.09.2004, p. 923-931.

Research output: Contribution to journalArticle

Cassinelli, Giuliana ; Supino, Rosanna ; Zuco, Valentina ; Lanzi, Cinzia ; Scovassi, A. Ivana ; Semple, Sean C. ; Zunino, Franco. / Role of c-myc protein in hormone refractory prostate carcinoma : Cellular response to paclitaxel. In: Biochemical Pharmacology. 2004 ; Vol. 68, No. 5. pp. 923-931.
@article{14a9112f507c4708bfabca461c5ee297,
title = "Role of c-myc protein in hormone refractory prostate carcinoma: Cellular response to paclitaxel",
abstract = "Amplification of the c-MYC proto-oncogene is a frequent alteration in hormone refractory prostate carcinomas (HRPC). In an attempt to investigate the role of c-myc in the cellular response to paclitaxel (PTX), we used two HRPC cell lines, DU145 and PC3, characterised by different levels of the protein and by different behaviour in response to taxane. In both cell lines, PTX-induced cell death was a caspase-mediated apoptosis. In DU145 cells, PTX induced an early apoptotic response associated with upregulation of c-myc restricted to the G2/M cell population. This event appeared delayed in the presence of c-myc antisense (AS-c-myc), suggesting an upstream regulation of the protein expression. In addition, the antisense approach provided evidence of an involvement of c-myc in the apoptotic response to the taxane. In contrast, in PC3 cells, the overexpressed c-myc was not modulated by drug-treatment and the addition of AS-c-myc did not affect the cell growth inhibition of PTX. In both cell lines, PTX-induced c-myc phosphorylation was concomitant with the mitotic arrest and not related to the modulation of the activation state of AKT and MAPK kinases. Our data indicate that the cellular response to PTX of HRPC cells can involve c-myc and suggest that its pro-apoptotic role is affected by the genetic background, thus supporting a complex and differentiated HRPC cell response to taxanes.",
keywords = "AS-c-myc, c-myc, c-myc antisense, hormone refractory prostate carcinoma, HRPC, ODN, oligodeoxynucleotide, paclitaxel, Paclitaxel, PI, propidium iodide, Prostatic neoplasms, PTX, Scr-ODN, scrambled oligodeoxynucleotide, TdT-mediated dUTP nick-end labelling, TUNEL",
author = "Giuliana Cassinelli and Rosanna Supino and Valentina Zuco and Cinzia Lanzi and Scovassi, {A. Ivana} and Semple, {Sean C.} and Franco Zunino",
year = "2004",
month = "9",
day = "1",
doi = "10.1016/j.bcp.2004.06.002",
language = "English",
volume = "68",
pages = "923--931",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Role of c-myc protein in hormone refractory prostate carcinoma

T2 - Cellular response to paclitaxel

AU - Cassinelli, Giuliana

AU - Supino, Rosanna

AU - Zuco, Valentina

AU - Lanzi, Cinzia

AU - Scovassi, A. Ivana

AU - Semple, Sean C.

AU - Zunino, Franco

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Amplification of the c-MYC proto-oncogene is a frequent alteration in hormone refractory prostate carcinomas (HRPC). In an attempt to investigate the role of c-myc in the cellular response to paclitaxel (PTX), we used two HRPC cell lines, DU145 and PC3, characterised by different levels of the protein and by different behaviour in response to taxane. In both cell lines, PTX-induced cell death was a caspase-mediated apoptosis. In DU145 cells, PTX induced an early apoptotic response associated with upregulation of c-myc restricted to the G2/M cell population. This event appeared delayed in the presence of c-myc antisense (AS-c-myc), suggesting an upstream regulation of the protein expression. In addition, the antisense approach provided evidence of an involvement of c-myc in the apoptotic response to the taxane. In contrast, in PC3 cells, the overexpressed c-myc was not modulated by drug-treatment and the addition of AS-c-myc did not affect the cell growth inhibition of PTX. In both cell lines, PTX-induced c-myc phosphorylation was concomitant with the mitotic arrest and not related to the modulation of the activation state of AKT and MAPK kinases. Our data indicate that the cellular response to PTX of HRPC cells can involve c-myc and suggest that its pro-apoptotic role is affected by the genetic background, thus supporting a complex and differentiated HRPC cell response to taxanes.

AB - Amplification of the c-MYC proto-oncogene is a frequent alteration in hormone refractory prostate carcinomas (HRPC). In an attempt to investigate the role of c-myc in the cellular response to paclitaxel (PTX), we used two HRPC cell lines, DU145 and PC3, characterised by different levels of the protein and by different behaviour in response to taxane. In both cell lines, PTX-induced cell death was a caspase-mediated apoptosis. In DU145 cells, PTX induced an early apoptotic response associated with upregulation of c-myc restricted to the G2/M cell population. This event appeared delayed in the presence of c-myc antisense (AS-c-myc), suggesting an upstream regulation of the protein expression. In addition, the antisense approach provided evidence of an involvement of c-myc in the apoptotic response to the taxane. In contrast, in PC3 cells, the overexpressed c-myc was not modulated by drug-treatment and the addition of AS-c-myc did not affect the cell growth inhibition of PTX. In both cell lines, PTX-induced c-myc phosphorylation was concomitant with the mitotic arrest and not related to the modulation of the activation state of AKT and MAPK kinases. Our data indicate that the cellular response to PTX of HRPC cells can involve c-myc and suggest that its pro-apoptotic role is affected by the genetic background, thus supporting a complex and differentiated HRPC cell response to taxanes.

KW - AS-c-myc

KW - c-myc

KW - c-myc antisense

KW - hormone refractory prostate carcinoma

KW - HRPC

KW - ODN

KW - oligodeoxynucleotide

KW - paclitaxel

KW - Paclitaxel

KW - PI

KW - propidium iodide

KW - Prostatic neoplasms

KW - PTX

KW - Scr-ODN

KW - scrambled oligodeoxynucleotide

KW - TdT-mediated dUTP nick-end labelling

KW - TUNEL

UR - http://www.scopus.com/inward/record.url?scp=3843078494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843078494&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2004.06.002

DO - 10.1016/j.bcp.2004.06.002

M3 - Article

C2 - 15294455

AN - SCOPUS:3843078494

VL - 68

SP - 923

EP - 931

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 5

ER -